Form 4 for COR Cencora
Accepted 2021-11-15 00:00:00 ET · period of report 2021-11-10 · accession 0001127602-21-029254 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-15 | 2021-11-10+ | COR | Krikorian Lazarus | SVP, CAO | M - OptEx | — | +3,861 | 20.1K | +24% | — |
| DM | 2021-11-15 | 2021-11-10+ | COR | Krikorian Lazarus | SVP, CAO | F - Tax | $122.53 | -3,281 | 17.7K | -16% | -$402.0K |
| D | 2021-11-15 | 2021-11-12 | COR | Krikorian Lazarus | SVP, CAO | A - Grant | — | +3,684 | 19.3K | +24% | — |
| D | 2021-11-15 | 2021-11-10 | COR | Krikorian Lazarus | SVP, CAO | A - Grant | — | +3,183 | 3,183 | New | — |
| DM | 2021-11-15 | 2021-11-10+ | COR | Krikorian Lazarus | SVP, CAO | M - OptEx | $0.00 | -3,861 | 2,811 | -58% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-10 | M | A | 1,405 | — | 16,220 | D | — | — | (F1) Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2021, 11/10/2022, and 11/10/2023. |
| 2 | Common | Common Stock | 2021-11-10 | F | D | 611 | $125.68 | 15,609 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-14 | F | D | 1,068 | $125.34 | 19,079 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-12 | F | D | 1,602 | $119.45 | 17,691 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-14 | M | A | 2,456 | — | 20,147 | D | — | — | (F3) Grant of restricted stock units on November 14, 2018 for no consideration and vested 100% on the third anniversary of the date of grant. |
| 6 | Common | Common Stock | 2021-11-12 | A | A | 3,684 | — | 19,293 | D | — | — | (F2) Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units. |
| 7 | Derivative | Restricted Stock Units | 2021-11-10 | A | A | 3,183 | — | 3,183 | D | $0.00 · — to — | 3,183 Common Stock | (F4) Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. |
| 8 | Derivative | Restricted Stock Units | 2021-11-14 | M | D | 2,456 | $0.00 | 0 | D | $0.00 · — to — | 2,456 Common Stock | (F3) Grant of restricted stock units on November 14, 2018 for no consideration and vested 100% on the third anniversary of the date of grant. |
| 9 | Derivative | Restricted Stock Units | 2021-11-10 | M | D | 1,405 | $0.00 | 2,811 | D | $0.00 · — to — | 1,405 Common Stock | (F1) Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2021, 11/10/2022, and 11/10/2023. |